Amgen Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| AMGN.VI | BIIB | NVS | 0R1F.IL | REGN | GLENMARK.NS | |
|---|---|---|---|---|---|---|
| Market cap | 224.59B | 37.40B | 301.68B | 133.94B | 97.44B | 755.57B |
| P/E (TTM) | 28.0 | 109.5 | 30.5 | 16.8 | 20.8 | 52.1 |
| Forward P/E | — | 15.6 | 16.0 | — | 13.3 | 27.8 |
| Price/book | 17.6 | 2.0 | 8.1 | 4.1 | 2.8 | 6.7 |
| Dividend yield | 2.17% | — | 2.90% | 4.04% | 0.41% | 0.19% |
| 1-year change | +40.99% | +56.83% | +23.41% | +26.24% | +34.37% | +44.56% |
| Today | +0.30% | −0.10% | −2.16% | 0.00% | +2.82% | +0.23% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All AMGN.VI news ›Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data
Technology Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data Licensing ALLISON GATLIN 08:00 AM ET 11/11/2026 After several high-profile setbacks among its competitors, Amgen (AMGN) unveiled test results…
Amgen slips after late-stage trial data for Sjögren's disease therapy
Nov 11, 2026, 8:47 AM ETAmgen Inc. (AMGN) StockBy: Dulan Lokuwithana, SA News EditorAmgen (AMGN) shares fell in premarket trading on Wednesday after the California-based pharma giant announced detailed results from a late-stage t
AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE
Updated Wed, November 11, 2026 at 1:00 PM UTCOnly Global Phase 3 Trial to Show Clinically Meaningful Improvements in Systemic Disease Activity and Patient-Reported Symptoms of Sjögren's Disease THOUSAND OAKS, Calif., Nov
Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?
Which belongs in a retiree’s account right now: Amgen (NASDAQ:AMGN | AMGN Price Prediction) or Regeneron (NASDAQ:REGN)? Both pay quarterly dividends and both beat consensus last quarter. Amgen has gained 43.94% year-to-date, while…
Amgen Inc. $AMGN Stock Acquired by Fulcrum Asset Management LLP
Posted by Tristan Rich on Nov 11th, 2026 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Fulcrum Asset Management LLP raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 65.5% dur
Amgen Inc. $AMGN Stock Acquired by Leuthold Group LLC
Posted by Danessa Lincoln on Nov 10th, 2026 Leuthold Group LLC increased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,409…
Amgen (AMGN) Receives a Buy from Scotiabank
Scotiabank analyst Louise Chen maintained a Buy rating on Amgen today and set a price target of $530.00. According to TipRanks, Chen is a 5-star analyst with an average return of 9.2% and a 54.39% success rate. Chen covers the Healthcare…
Amgen (AMGN) Gets a Hold from Guggenheim
In a report released yesterday, Vamil Divan from Guggenheim maintained a Hold rating on Amgen, with a price target of $435.00. The company’s shares closed yesterday at $478.48. According to TipRanks, Divan is a 5-star analyst with an…
Transcript : PepGen Inc. - Special Call
Presentation Operator Message Operator Welcome to the PepGen conference call to discuss top line results from lowest dose MAD cohort in the Phase II FREEDOM2 study, demonstrating promising safety,... Transcript : PepGen Inc. - Special Call…
Icelandic Genetics Helped Shape Amgen’s MariTide Drug
According to the company, the work identified naturally occurring genetic signals around the GIP receptor. This strengthened the case for a drug designed to block that pathway while activating GLP-1. Amgen’s account says the turning point…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com42
- marketbeat.com39
- theglobeandmail.com22
- themarketsdaily.com19
- fool.com14
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.